...
首页> 外文期刊>Nanotechnology >Study of the intestinal uptake and permeability of gold nanoparticles using both in vitro and in vivo approaches
【24h】

Study of the intestinal uptake and permeability of gold nanoparticles using both in vitro and in vivo approaches

机译:在体外和体内近似使用金纳米颗粒的肠道吸收和渗透性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Gold nanoparticles (AuNPs) are highly attractive to biomedical applications. Here, we investigated the effects of (i) ca. 15 nm spherical AuNPs capped with citrate or 11-mercaptoundecanoic acid (MUA) and (ii) ca. 60 nm spherical citrate-capped AuNPs, and ca. 60 nm MUA-capped star-shaped AuNPs on the cytotoxicity, cellular uptake and permeability, using media supplemented or not with 1% fetal bovine serum (FBS) on caucasian colon adenocarcinoma Caco-2 cells. In addition, the colloidal stability of the nanoparticles in media (supplemented or not) was assessed after 24 h-incubations at 60 mu M. The 60 nm gold nanospheres and stars were administrated orally to Wistar rats in order to evaluate their systemic absorption and biodistribution after 24 h. At non-supplemented media settings, citrate-capped gold nanoparticles seem to be more toxic than their MUA-capped counterparts. Also, smaller nanoparticles show higher toxicity than larger ones. The use of cell culture media with 1% FBS not only increased the stability of all AuNPs, as also significantly reduced their cytotoxicity. In the uptake studies, higher AuNPs incorporation was noticed in serum supplemented media, this effect being particularly significant for the 60 nm nanoparticles. Cellular incorporation depended also on the capping agent and size. None of the tested samples crossed the in vitro intestinal barrier. Confirming the in vitro results, the in vivo biodistribution study of the 60 nm AuNPs orally given to rats showed that their systemic absorption is low and that they are mainly eliminated through the faeces. Altogether, these preliminary results suggest that our novel AuNPs have high potential to be considered promising candidates for application in diagnostics or drug delivery at the intestinal level, showing high biocompatibility. However, unless it is desired that these nanomaterials avoid systemic absorption upon oral administration, additional functionalization should be sought to increase their low bioavailability.
机译:金纳米粒子(AUNPS)对生物医学应用非常有吸引力。在这里,我们调查了(i)CA的效果。用柠檬酸盐或11-巯基癸酸(MUA)和(ii)CA封端15nm球形剖腹产剖腹产。 60 nm球形柠檬酸覆盖的aUNP和CA。在细胞毒性,细胞摄取和渗透性上,使用补充或不含1%胎儿牛血清(FBS)的培养基,在白种人结肠腺癌Caco-2细胞上使用培养基,使用60nm的静脉曲张的星形剖腹产。此外,在60μmM的24小时孵育后,评估培养基中纳米颗粒的胶体稳定性.60nm金纳米球和恒星对Wi​​star大鼠口服给予,以评估其全身吸收和生物分布。 24小时后。在不补充的介质设置下,柠檬酸盖金纳米颗粒似乎比其MUA封端​​的对应物更毒性。而且,较小的纳米颗粒表现出高于较大的毒性。使用1%FBS的细胞培养基不仅增加了所有AUNP的稳定性,也显着降低了它们的细胞毒性。在摄取研究中,在补充介质中均注意到较高的AUNPS掺入,对于60nm纳米颗粒特别显着。细胞掺入也依赖于封端剂和大小。没有测试的样品越过体外肠道屏障。确认体外结果,对60nm的体内生物分布研究口服给予大鼠的60nm Aunps的研究表明,其全身吸收低,它们主要通过粪便消除。完全是,这些初步结果表明,我们的新型AUNPS具有很高的潜力,被认为是在肠道水平诊断或药物递送中申请的有希望的候选者,显示出高的生物相容性。然而,除非需要这些纳米材料避免口服给药时的全身吸收,应寻求额外的官能化增加其低生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号